IMSS is a way with artificial intelligence to support patients with skin cancer

Researchers from Mexican Social Security Institute (IMSS) I put a tool artificial intelligence , Which can evaluate if the patient is with melanomaand It will respond or not to treat immunotherapy.

This method, which uses clinical data for people with cancer, can predict whether the malignant tumor can be suppressed with the application of immune therapy, through which immune cells remove cancer cells.

The above will contribute to doctors to determine more accurate Treatment of treatment Laura Cecilia Bonifz Alfonso, the health research coordinator for the IMSS education and research unit, said the cancer patient should receive a cancer patient.

The idea is that our project can support the choice of a doctor’s treatment, that is, the doctor can do this test, and with this he decides whether it is appropriate for this treatment to occur or request an alternative strategy, “the investigation manager also explained.

For his part, Sarai Gizel de Leon Rodriguez, a researcher associated with the Medical Research Unit in Immunology at the Pediatric Hospital at the 21st Pediatric Medical Center, added that in the case of immunotherapy to prohibit control points, she stated that patients who were treated with this treatment reach a global survival for about 72 months.

On the contrary, in traditional treatments to attack cancer, such as chemotherapy, the average survival is usually 10 months.

Our goal is that through this research in future patients who suffer from this disease can be treated more accurately, using the treatment that works better for them, not only to maintain skin cancer, which is these tumors that have arisen in the skin. But to transfer it to other types of tumors such as: breast cancer, lung, etc., which exposes the use of this same treatment. “

JCs